Vanguard FTSE Developed Europe UCITS ETF (VFDEF)
| Assets | 3.69B |
| Expense Ratio | 0.10% |
| PE Ratio | 14.37 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +17.73% |
| Volume | 3,060 |
| Open | 49.59 |
| Previous Close | 49.25 |
| Day's Range | 49.59 - 49.59 |
| 52-Week Low | 40.15 |
| 52-Week High | 49.76 |
| Beta | n/a |
| Holdings | 529 |
| Inception Date | May 21, 2013 |
About VFDEF
Vanguard FTSE Developed Europe UCITS ETF is an exchange traded fund launched by Vanguard Group (Ireland) Limited. It is co-managed by Vanguard Asset Management, Limited and The Vanguard Group, Inc. It invests in the public equity markets of developed countries in Europe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of large-cap and mid-cap companies. The fund seeks to replicate the performance of the FTSE Developed Europe Index, by investing in the stocks of companies as per their weightings in the index. Vanguard FTSE Developed Europe UCITS ETF was formed on May 21, 2013 and is domiciled in Ireland.
Performance
VFDEF had a total return of 17.73% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.14%.
Top 10 Holdings
18.93% of assets| Name | Symbol | Weight |
|---|---|---|
| SAP SE | SAP | 2.65% |
| ASML Holding N.V. | ASML | 2.30% |
| Nestlé S.A. | NESN | 2.20% |
| Novartis AG | NOVN | 1.81% |
| Roche Holding AG | ROG | 1.77% |
| Novo Nordisk A/S | NOVO.B | 1.77% |
| AstraZeneca PLC | AZN | 1.73% |
| HSBC Holdings plc | HSBA | 1.68% |
| Shell plc | SHEL | 1.61% |
| Siemens Aktiengesellschaft | SIE | 1.43% |